SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-20-000037
Filing Date
2020-11-13
Accepted
2020-11-13 16:17:17
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gale-20200930.htm   iXBRL 10-Q 1158917
2 EX-10.3 sls20200930ex103.htm EX-10.3 119729
3 EX-31.1 sls20200930ex311.htm EX-31.1 8285
4 EX-31.2 sls20200930ex312.htm EX-31.2 8289
5 EX-32.1 sls20200930ex321.htm EX-32.1 6702
11 gale-20200930_g1.jpg GRAPHIC 30719
  Complete submission text file 0001390478-20-000037.txt   5634767

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20200930.xsd EX-101.SCH 43503
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20200930_cal.xml EX-101.CAL 60537
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20200930_def.xml EX-101.DEF 191910
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20200930_lab.xml EX-101.LAB 484755
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20200930_pre.xml EX-101.PRE 320138
12 EXTRACTED XBRL INSTANCE DOCUMENT gale-20200930_htm.xml XML 925100
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 201311709
SIC: 2834 Pharmaceutical Preparations